Factors influencing the therapeutic effect of muscle afferent block for oromandibular dystonia and dyskinesia: implications for their distinct pathophysiology
- 31 October 2002
- journal article
- Published by Elsevier BV in International Journal of Oral & Maxillofacial Surgery
- Vol. 31 (5), 499-505
- https://doi.org/10.1054/ijom.2002.0291
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- The pathophysiology of primary dystoniaBrain, 1998
- TolcaponeNeurology, 1998
- Tonic vibration reflex and muscle afferent block in writer's crampAnnals of Neurology, 1995
- Muscle afferent block by intramuscular injection of lidocaine for the treatment of writer's crampMuscle & Nerve, 1995
- Therapeutic Uses of Botulinum ToxinThe New England Journal of Medicine, 1991
- Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm.Journal of Neurology, Neurosurgery & Psychiatry, 1990
- Botulinum Toxin Injection for the Treatment of Oromandibular DystoniaAnnals of Otology, Rhinology & Laryngology, 1989
- PATHOPHYSIOLOGY OF BLEPHAROSPASM AND OROMANDIBULAR DYSTONIABrain, 1985
- Blepharospasm and orofacial‐cervical dystonia: Clinical and pharmacological findings in 100 patientsAnnals of Neurology, 1983
- The Effects of Several Alcohols on the Properties of the Squid Giant AxonThe Journal of general physiology, 1964